NDC product
Mag 440
NDC 28595-710 · Allegis Pharmaceuticals, LLC
Key facts
| Product NDC | 28595-710 |
|---|---|
| Proprietary name | Mag 440 |
| Nonproprietary name | Megnesium Oxide |
| Substances | MAGNESIUM OXIDE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Allegis Pharmaceuticals, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M001 |
| Pharmacologic classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA] and 2 more |
| Marketing start | Jan 27, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: